• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤的预后因素。一项回归分析。

Prognostic factors in osteosarcomas. A regression analysis.

作者信息

Bentzen S M, Poulsen H S, Kaae S, Jensen O M, Johansen H, Mouridsen H T, Daugaard S, Arnoldi C

机构信息

Department of Oncology, Radiumstationen, Aarhus, Denmark.

出版信息

Cancer. 1988 Jul 1;62(1):194-202. doi: 10.1002/1097-0142(19880701)62:1<194::aid-cncr2820620129>3.0.co;2-8.

DOI:10.1002/1097-0142(19880701)62:1<194::aid-cncr2820620129>3.0.co;2-8
PMID:3164231
Abstract

A multivariate regression analysis of survival data, using the Cox proportional hazards model (PHM), was performed on the retrospective material of 184 osteosarcoma patients treated at the Aarhus and Copenhagen oncology centers, Denmark, from 1963 to 1984. All patients were previously untreated. Radical surgery, in general ablative when possible, was the primary treatment goal throughout this period. A number of clinical and pathologic variables were tested in the model to elucidate their prognostic importance. Tumors localized to the trunk, pelvis, or femur, and symptom duration of less than 6 months were poor prognostic signs. Tumors dominated by fibroblastic cells and a patient age of approximately 25 to 30 years were associated with an especially good prognosis. The prognosis worsened with advancing age. Children, adolescents, and adults ages 5 to 25 years had significantly poorer prognosis than young adults 25 to 30 years of age. Sex, radiologic appearance, and year of referral had no significant prognostic value in this series. Based on the regression model, a prognostic index is derived and survival is calculated for a good and a poor prognostic case. The overall 10-year survival with one standard deviation was 28.6 +/- 3.5%. Cancer deaths continue to occur 10 years after initial treatment, and the estimated hazard rate is still four times greater than that of a sex- and age-matched group of healthy individuals.

摘要

利用Cox比例风险模型(PHM)对生存数据进行多变量回归分析,该分析基于1963年至1984年在丹麦奥胡斯和哥本哈根肿瘤中心接受治疗的184例骨肉瘤患者的回顾性资料。所有患者此前均未接受过治疗。在此期间,根治性手术(尽可能进行广泛切除)是主要治疗目标。在模型中测试了一些临床和病理变量,以阐明它们的预后重要性。肿瘤位于躯干、骨盆或股骨,以及症状持续时间少于6个月是预后不良的迹象。以成纤维细胞为主的肿瘤和年龄约为25至30岁的患者预后特别好。预后随着年龄增长而恶化。5至25岁的儿童、青少年和成年人的预后明显比25至30岁的年轻人差。在该系列中,性别、放射学表现和转诊年份没有显著的预后价值。基于回归模型,得出一个预后指数,并计算出预后良好和预后不良病例的生存率。总体10年生存率及一个标准差为28.6 +/- 3.5%。初始治疗10年后仍有癌症死亡发生,估计风险率仍比性别和年龄匹配的健康个体组高四倍。

相似文献

1
Prognostic factors in osteosarcomas. A regression analysis.骨肉瘤的预后因素。一项回归分析。
Cancer. 1988 Jul 1;62(1):194-202. doi: 10.1002/1097-0142(19880701)62:1<194::aid-cncr2820620129>3.0.co;2-8.
2
Survival rate and prognostic factors of conventional osteosarcoma in Northern Thailand: A series from Chiang Mai University Hospital.泰国北部传统骨肉瘤的生存率及预后因素:清迈大学医院的系列研究
Cancer Epidemiol. 2015 Dec;39(6):956-63. doi: 10.1016/j.canep.2015.10.016. Epub 2015 Nov 9.
3
Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.恶性原发性骨脊柱肿瘤患者的生存率:来自 1973 年至 2003 年监测、流行病学和最终结果(SEER)数据库的结果。
J Neurosurg Spine. 2011 Feb;14(2):143-50. doi: 10.3171/2010.10.SPINE10189. Epub 2010 Dec 24.
4
Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.在丹麦东部的一个单一机构进行了 21 年的研究,评估了高级肢端骨肉瘤诊断时的生存和预后因素。
Acta Oncol. 2018 Mar;57(3):420-425. doi: 10.1080/0284186X.2017.1351620. Epub 2017 Jul 25.
5
The extremity localized classic osteosarcomas have better survival than the axial non-classics.局限性经典型骨外骨肉瘤的存活率高于轴外非经典型。
World J Surg Oncol. 2018 Feb 23;16(1):39. doi: 10.1186/s12957-018-1344-3.
6
The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.根据年龄分组的骨肉瘤患者的结局和预后因素:一项日本全国性研究,重点关注年龄差异。
BMC Cancer. 2018 May 31;18(1):614. doi: 10.1186/s12885-018-4487-2.
7
Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: A retrospective cohort study of 153 patients.肢体长骨近端位置是骨肉瘤的不良预后因素:一项对153例患者的回顾性队列研究。
Acta Oncol. 2016 Aug;55(8):1036-9. doi: 10.3109/0284186X.2016.1156740. Epub 2016 May 4.
8
Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.新辅助化疗前后骨肉瘤中肿瘤抑制因子的预后价值。
BMC Cancer. 2015 May 9;15:379. doi: 10.1186/s12885-015-1397-4.
9
[Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].骨肉瘤患者的生存分析及预后因素的影响
Acta Orthop Traumatol Turc. 2007;41(3):211-9.
10
Trends and variability in survival among patients with osteosarcoma: a 7-year update.骨肉瘤患者生存率的趋势及变异性:7年更新情况
Mayo Clin Proc. 1985 Feb;60(2):91-104. doi: 10.1016/s0025-6196(12)60293-6.

引用本文的文献

1
Osteosarcoma: A comprehensive review of model systems and experimental therapies.骨肉瘤:模型系统与实验性治疗的全面综述
Med Res Arch. 2024 Nov;12(11). doi: 10.18103/mra.v12i11.6000. Epub 2024 Nov 29.
2
Mapping the Single-Cell Differentiation Landscape of Osteosarcoma.绘制骨肉瘤单细胞分化图谱。
Clin Cancer Res. 2024 Aug 1;30(15):3259-3272. doi: 10.1158/1078-0432.CCR-24-0563.
3
mtDNA Heteroplasmy: Origin, Detection, Significance, and Evolutionary Consequences.线粒体DNA异质性:起源、检测、意义及进化后果
Life (Basel). 2021 Jun 29;11(7):633. doi: 10.3390/life11070633.
4
Osteosarcoma Overview.骨肉瘤概述
Rheumatol Ther. 2017 Jun;4(1):25-43. doi: 10.1007/s40744-016-0050-2. Epub 2016 Dec 8.
5
Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors.骨肉瘤:组织病理学中的诊断难题及预后因素
Indian J Orthop. 2014 May;48(3):247-54. doi: 10.4103/0019-5413.132497.
6
miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells.miR-183 通过下调 F5M2 细胞中 Ezrin 的表达抑制骨肉瘤的转移。
Int J Mol Med. 2012 Nov;30(5):1013-20. doi: 10.3892/ijmm.2012.1111. Epub 2012 Aug 24.
7
Expression change of ezrin as a prognostic factor in primary osteosarcoma.Ezrin 表达变化作为原发性骨肉瘤的预后因素。
Med Oncol. 2011 Dec;28 Suppl 1:S636-43. doi: 10.1007/s12032-010-9684-z. Epub 2010 Sep 22.
8
Clinical value of ezrin expression in primary osteosarcoma.原发性骨肉瘤中 ezrin 表达的临床价值。
Cancer Res Treat. 2009 Sep;41(3):138-44. doi: 10.4143/crt.2009.41.3.138. Epub 2009 Sep 28.
9
Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients.年龄作为骨肉瘤患者的预后因素:对 438 例患者的分析。
J Cancer Res Clin Oncol. 2010 Apr;136(4):561-70. doi: 10.1007/s00432-009-0690-5. Epub 2009 Sep 27.
10
Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation.免疫组织化学评估血管生成、增殖活性、p53表达及多药耐药性对骨肉瘤无预后影响:一项比较临床病理研究
Sarcoma. 2008;2008:874075. doi: 10.1155/2008/874075. Epub 2009 Feb 25.